Vonlerolizumab Biosimilar – Anti-TNFRSF4, CD134 mAb – Research Grade

Reference:
Size

,

Brand

Product type

Clonality

Expression system

Applications

,

Product nameVonlerolizumab Biosimilar - Anti-TNFRSF4, CD134 mAb - Research Grade
SourceCAS 1638935-72-4
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsVonlerolizumab,MOXR-0916,MOXR0916,RG-7888,RO7021608,TNFRSF4, CD134,anti-TNFRSF4, CD134
ReferencePX-TA1424
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Vonlerolizumab Biosimilar - Anti-TNFRSF4/CD134 mAb - Research Grade

General information on Anti-TNFRSF4/CD134[Homo sapiens] (Vonlerolizumab) Monoclonal Antibody

Vonlerolizumab is investigated for thr treatment of Locally Advanced or Metastatic Urothelial Carcinoma.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Vonlerolizumab Biosimilar – Anti-TNFRSF4, CD134 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human OX40 recombinant protein
Antigen

Human OX40 recombinant protein

PX-P6017 385€
Stable Isotope Labelled Vonlerolizumab Biosimilar – Anti-TNFRSF4/CD134 mAb – Research Grade
SIL

Stable Isotope Labelled Vonlerolizumab Biosimilar – Anti-TNFRSF4/CD134 mAb – Research Grade

PX-TA1424-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products